[Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
Pecori-Giraldi
J
J
Collini
S
S
Planner-Terzaghi
A
A
Arrico
L
L
Grechi
G
G
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000368:Aged; D015784:Betaxolol; D002986:Clinical Trials as Topic; D005260:Female; D005541:Forced Expiratory Volume; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects*; D011897:Random Allocation; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects*; D014797:Vital Capacity / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C006034:befunolol; D013999:Timolol; D015784:Betaxolol
Timolol, Betaxolol und Befunolol in der Glaukombehandlung. Untersuchung über die bronchopulmonalen Effekte.